<DOC>
	<DOCNO>NCT02476890</DOCNO>
	<brief_summary>This double-blind , randomize , 2 period , crossover study 36 healthy chronic cough subject .</brief_summary>
	<brief_title>Effect AF-219 Cough Reflex Sensitivity ( Cough Challenge )</brief_title>
	<detailed_description>Approximately 24 chronic cough subject 12 healthy subject meet entry criterion randomly assign AF-219 placebo . There Screening period , two Baseline Visits , two Treatment period minimum 48-hour washout period treatment . Subjects return two week last Treatment Visit Follow-up Visit . At Baseline Treatment period , cough sensitivity measure standard clinical methodology incorporate four cough challenge ( capsaicin , citric acid , ATP , distilled water ) . Daytime cough monitoring perform Baseline two treatment period ( cough subject ) .</detailed_description>
	<mesh_term>Cough</mesh_term>
	<criteria>Have provide write informed voluntary consent ; Be able speak , read , understand English ; Be male female , race , 18 80 year age , inclusive ; Have body mass index ( BMI ) â‰¥ 18 &lt; 35 kg/m2 ; Be good general health clinically relevant abnormality base medical history , physical examination , clinical laboratory evaluation ( hematology , clinical chemistry , urinalysis ) , 12 lead electrocardiogram ; Be nonsmoker least 5 year ; If female childbearing potential ( i.e. , undergone hysterectomy bilateral oophorectomy ) postmenopausal ( defined menses least 12 month ) , agree use 2 form acceptable birth control ; male , and/or partner childbearing potential agree use 2 form acceptable birth control ; Subjects chronic cough ; Be able communicate effectively Investigator study center personnel agree comply study procedure restriction . History upper respiratory tract infection recent significant change pulmonary status within 4 week Baseline Visit ( Day 0 ) ; Have acute worsen asthma ; Do cough ATP Capsaicin Citric acid challenge screen cough twice two high concentration test solution ; History concurrent malignancy recurrence malignancy within 2 year prior Screening ( include subject &lt; 3 excise basal cell carcinoma ) ; History diagnosis drug alcohol dependency abuse within approximately last 3 year ; Clinically significant abnormal electrocardiogram ( ECG ) Screening ; Significantly abnormal laboratory test Screening ; Pregnant breastfeeding ; Other severe , acute , chronic medical psychiatric condition laboratory abnormality may increase risk associate trial participation investigational product administration may interfere interpretation trial result , judgment Investigator Sponsor , would make subject inappropriate entry trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>